Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-099629
Filing Date
2025-07-29
Accepted
2025-07-29 16:09:29
Documents
17
Effectiveness Date
2025-07-29

Document Format Files

Seq Description Document Type Size
1 S-8 alks-20250729.htm S-8 150014
2 EX-5.1 alks-ex5_1.htm EX-5.1 105178
3 EX-23.1 alks-ex23_1.htm EX-23.1 3113
4 EX-FILING FEES alks-exfiling_fees.htm   iXBRL EX-FILING FEES 12862
5 GRAPHIC img139586189_0.jpg GRAPHIC 109157
6 GRAPHIC img139586189_1.jpg GRAPHIC 399520
7 GRAPHIC img139586189_2.jpg GRAPHIC 22461
  Complete submission text file 0000950170-25-099629.txt   1120470

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT alks-exfiling_fees_htm.xml XML 4874
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289037 | Film No.: 251161929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)